

News & Views: Tag: Behaviour change metrics

After another exciting year, Fabrice Allum, Managing Director at Porterhouse Insights, reflects on the benefits of cross-functional working for our pharmaceutical clients.
Fabrice Allum, MD of Porterhouse Insights, looks at behaviour change, and the value of measuring the real-world impact of medical communication and education programmes on behaviour.
Sponsoring congress activities presents an important opportunity for pharmaceutical companies and comprises a significant part of both medical and commercial budgets. As a result, pharmaceutical companies are keen to show a return on investment for this ongoing annual expenditure, so there is more demand than ever to indicate areas where analytics can be shown to clearly demonstrate the value of the meetings.
Fabrice Allum, managing director of Porterhouse Insights, looks at behaviour change and introduces the Porterhouse BPS.